fpl 57231 has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 3 studies
Studies (fpl 57231) | Trials (fpl 57231) | Recent Studies (post-2010) (fpl 57231) | Studies (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) | Trials (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) | Recent Studies (post-2010) (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) |
---|---|---|---|---|---|
30 | 0 | 0 | 2,577 | 27 | 327 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heymann, MA; Schreiber, MD; Soifer, SJ | 1 |
Baker, R; Cassin, S; Gause, GE | 1 |
Bryson, SE; McKechnie, K; Pacitti, N; Parratt, JR; Rodger, IW | 1 |
3 other study(ies) available for fpl 57231 and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
Article | Year |
---|---|
Leukotriene antagonists attenuate thromboxane-inducible pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Animals, Newborn; Blood Pressure; Cardiac Output; Chromones; Epoprostenol; Hypertension, Pulmonary; Lipoxygenase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Sheep; SRS-A; Thromboxane A2 | 1989 |
Specificity of FPL 57231 for leukotriene D4 receptors in fetal pulmonary circulation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Chromones; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Lipoxygenase; Lung; Prostaglandin Endoperoxides, Synthetic; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Pyrazoles; Receptors, Leukotriene; Receptors, Prostaglandin; Sheep; SRS-A; Vascular Resistance | 1988 |
Leukotriene antagonist FPL 57231 prevents the acute pulmonary effects of Escherichia coli endotoxin in cats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 6-Ketoprostaglandin F1 alpha; Airway Resistance; Animals; Blood Pressure; Cats; Chromones; Dinoprost; Endotoxins; Escherichia coli; Evaluation Studies as Topic; Hypertension, Pulmonary; Infusions, Intravenous; Lung Compliance; Male; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Pulmonary Circulation; Shock, Septic; SRS-A; Thromboxane B2 | 1987 |